Bob G. Gower - 09 Dec 2022 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Role: Director
Signature: /s/ Bob G Gower
Issuer symbol: ENSC
Transactions as of: 09 Dec 2022
Net transactions value: +$500,000
Form type: 4
Filing time: 01 Feb 2023, 17:06:45 UTC
Previous filing: 27 Jun 2022
Next filing: 02 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENSC	Common Stock	Purchase	$500,000	+357,143	+90%	$1.40	753,095	09 Dec 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENSC	Warrants	Award		+714,286	+34357%		716,365	09 Dec 2022	Common Stock	714,286	$1.40	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On October 28, 2022, Ensysce Biosciences, Inc. (the "Company"), pursuant to an amendment to the Company's Third Amended and Restated Certificate of Incorporation, effectuated a one-for-twenty reverse stock split of the Company's common stock, par value $0.0001 (the "Common Stock").
F2	On December 9, 2022, Mr. Gower purchased 357,143 shares of Common Stock at a price of $1.40 per share.
F3	On December 9, 2022, Mr. Gower purchased 357,143 warrants to purchase 714,286 shares of Common Stock with an exercise price of $1.40 per share (the "Warrants") in an underwritten offering further described on the Company's Prospectus filed pursuant to Rule 424(b)(4) (File No. 333-268038) filed with the Commission on December 9, 2022. The Warrants are immediately exercisable and may be exercised until five years from the date of issuance.